BURNETT JOSEPH 4

What Happened
Joseph M. Burnett, President, CEO and a director of ClearPoint Neuro (CLPT), sold 2,943 shares in an open-market transaction on January 26, 2026. The weighted average sale price was $15.57 per share for proceeds of approximately $45,823. This was a sale (not a purchase or option exercise).

Key Details

• Transaction date: 2026-01-26 (reported on Form 4 filed 2026-01-27) — filing appears timely.
• Price: weighted average $15.57; individual sale prices ranged from $15.23 to $15.65.
• Proceeds: ~$45,823 for 2,943 shares.
• Ownership: shares sold were owned directly by the Joseph M. Burnett Trust dated 10/20/2022; Burnett is trustee. The Form 4 excerpt provided does not state Burnett’s total holdings after the sale.
• Footnotes: sale was made under a pre-established Rule 10b5-1 trading plan adopted June 11, 2025; the filer can provide a breakdown of how many shares sold at each price within the reported range.
• Transaction code: S = Sale.

Context
Sales made under a 10b5-1 plan are prearranged and commonly used to regularly monetize holdings; they are generally considered routine and do not necessarily indicate a change in the insider’s view of the company. For retail investors, purchases often carry more weight as signals than routine sales, though monitoring insider ownership levels and frequency of sales remains useful.